MGC Pharmaceuticals' proprietary ZAM app "about good practice"

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner after announcing the enrolment of the first patient in its proprietary data collection App and machine learning algorithm, ZAM.

Clements explains why MGC is investing in medical technology, saying that "this is about good practice."

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  198.72
-5.36 (-2.63%)
AAPL  260.42
-15.08 (-5.47%)
AMD  206.60
-6.98 (-3.27%)
BAC  52.51
-1.34 (-2.50%)
GOOG  308.54
-2.79 (-0.90%)
META  649.48
-19.21 (-2.87%)
MSFT  402.29
-2.08 (-0.52%)
NVDA  187.51
-2.54 (-1.34%)
ORCL  156.68
-0.48 (-0.31%)
TSLA  415.61
-12.66 (-2.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.